BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7605982)

  • 1. High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas.
    Camilleri-Broët S; Davi F; Feuillard J; Bourgeois C; Seilhean D; Hauw JJ; Raphaël M
    Blood; 1995 Jul; 86(2):432-5. PubMed ID: 7605982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma.
    Niedobitek G; Agathanggelou A; Rowe M; Jones EL; Jones DB; Turyaguma P; Oryema J; Wright DH; Young LS
    Blood; 1995 Jul; 86(2):659-65. PubMed ID: 7605996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomas.
    Carbone A; Gloghini A; Zagonel V; Tirelli U
    Blood; 1996 Feb; 87(3):1202-4. PubMed ID: 8562951
    [No Abstract]   [Full Text] [Related]  

  • 4. Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations.
    Knecht H; Raphaël M; McQuain C; Rothenberger S; Pihan G; Camilleri-Broët S; Bachmann E; Kershaw GR; Ryan S; Kittler EL; Quesenberry PJ; Schlaifer D; Woda BA; Brousset P
    Blood; 1996 Feb; 87(3):876-81. PubMed ID: 8562956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders.
    Murray PG; Swinnen LJ; Constandinou CM; Pyle JM; Carr TJ; Hardwick JM; Ambinder RF
    Blood; 1996 Jan; 87(2):706-11. PubMed ID: 8555494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.
    Araujo I; Foss HD; Bittencourt A; Hummel M; Demel G; Mendonca N; Herbst H; Stein H
    Blood; 1996 Jun; 87(12):5279-86. PubMed ID: 8652843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bcl-2, Epstein-Barr virus-latent membrane protein, EBNA-1, and EBNA-2 staining in posttransplantation lymphoproliferative disorders.
    Chetty R; Biddolph S; Gatter K
    Blood; 1996 Jun; 87(12):5395. PubMed ID: 8652861
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.
    Larocca LM; Capello D; Rinelli A; Nori S; Antinori A; Gloghini A; Cingolani A; Migliazza A; Saglio G; Cammilleri-Broet S; Raphael M; Carbone A; Gaidano G
    Blood; 1998 Aug; 92(3):1011-9. PubMed ID: 9680371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging pathways in the development of AIDS-related lymphomas.
    Carbone A
    Lancet Oncol; 2003 Jan; 4(1):22-9. PubMed ID: 12517536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent Epstein-Barr virus genes.
    Finke J; Fritzen R; Ternes P; Trivedi P; Bross KJ; Lange W; Mertelsmann R; Dölken G
    Blood; 1992 Jul; 80(2):459-69. PubMed ID: 1378321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.
    Nador RG; Cesarman E; Chadburn A; Dawson DB; Ansari MQ; Sald J; Knowles DM
    Blood; 1996 Jul; 88(2):645-56. PubMed ID: 8695812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.
    Horenstein MG; Nador RG; Chadburn A; Hyjek EM; Inghirami G; Knowles DM; Cesarman E
    Blood; 1997 Aug; 90(3):1186-91. PubMed ID: 9242551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors.
    Camilleri-Broët S; Davi F; Feuillard J; Seilhean D; Michiels JF; Brousset P; Epardeau B; Navratil E; Mokhtari K; Bourgeois C; Marelle L; Raphäel M; Hauw JJ
    Hum Pathol; 1997 Mar; 28(3):367-74. PubMed ID: 9042803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
    D'Souza B; Rowe M; Walls D
    J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma.
    Schlaifer D; Brousset P; Attal M; Massip P; Payen C; Marchou B; Huguet F; Muller C; Laurent G; Pris J
    Histopathology; 1994 Jul; 25(1):77-82. PubMed ID: 7959648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression.
    Carbone A; Gaidano G; Gloghini A; Pastore C; Saglio G; Tirelli U; Dalla-Favera R; Falini B
    Am J Pathol; 1997 Jan; 150(1):155-65. PubMed ID: 9006332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
    Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
    Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
    Toomey NL; Deyev VV; Wood C; Boise LH; Scott D; Liu LH; Cabral L; Podack ER; Barber GN; Harrington WJ
    Oncogene; 2001 Oct; 20(48):7029-40. PubMed ID: 11704827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.